ADVANCING IMMUNOTHERAPY in ONCOLOGY, created in 2008 (United States), from 496 sister brands and 17477 competing brands. The ADVANCING IMMUNOTHERAPY in ONCOLOGY brand is owned by BRISTOL-MYERS SQUIBB COMPANY, a company listed in New York. The sector of ADVANCING IMMUNOTHERAPY in ONCOLOGY is Drug Manufacturers.

ADVANCING IMMUNOTHERAPY in ONCOLOGY is a brand of BRISTOL-MYERS SQUIBB COMPANY (BMY) Sustainability

International deposit : 2008 Business sector Drug Manufacturers
Here is the evolution of interest in BRISTOL-MYERS SQUIBB COMPANY "sustainability" criteria around the world over the past five years. The graph shows the evolution of the search rate over time, where the value 100 indicates the week with the most searches.
What is the brand's web response on its sustainability
Result of Google's query: "ADVANCING IMMUNOTHERAPY in ONCOLOGY sustainability"
Sustainability -> Share price